Xbrane Biopharma Balance Sheet Health
Financial Health criteria checks 3/6
Xbrane Biopharma has a total shareholder equity of SEK260.1M and total debt of SEK124.2M, which brings its debt-to-equity ratio to 47.7%. Its total assets and total liabilities are SEK839.7M and SEK579.5M respectively.
Key information
47.7%
Debt to equity ratio
SEK 124.18m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 30.59m |
| Equity | SEK 260.15m |
| Total liabilities | SEK 579.52m |
| Total assets | SEK 839.67m |
Recent financial health updates
Is Xbrane Biopharma (STO:XBRANE) In A Good Position To Deliver On Growth Plans?
Jun 04
We Think Xbrane Biopharma (STO:XBRANE) Needs To Drive Business Growth Carefully
Nov 05We Think Xbrane Biopharma (STO:XBRANE) Can Afford To Drive Business Growth
Jan 12Recent updates
Even With A 30% Surge, Cautious Investors Are Not Rewarding Xbrane Biopharma AB (publ)'s (STO:XBRANE) Performance Completely
Sep 30Market Cool On Xbrane Biopharma AB (publ)'s (STO:XBRANE) Revenues Pushing Shares 34% Lower
Aug 05Market Might Still Lack Some Conviction On Xbrane Biopharma AB (publ) (STO:XBRANE) Even After 32% Share Price Boost
Jun 21Is Xbrane Biopharma (STO:XBRANE) In A Good Position To Deliver On Growth Plans?
Jun 04We Think Xbrane Biopharma (STO:XBRANE) Needs To Drive Business Growth Carefully
Nov 05Market Sentiment Around Loss-Making Xbrane Biopharma AB (publ) (STO:XBRANE)
Mar 24Xbrane Biopharma AB (publ) (STO:XBRANE) Insiders Increased Their Holdings
Mar 02Xbrane Biopharma AB (publ)'s (STO:XBRANE) Intrinsic Value Is Potentially 28% Above Its Share Price
Feb 10We Think Xbrane Biopharma (STO:XBRANE) Can Afford To Drive Business Growth
Jan 12Financial Position Analysis
Short Term Liabilities: XBRANE's short term assets (SEK639.0M) exceed its short term liabilities (SEK474.2M).
Long Term Liabilities: XBRANE's short term assets (SEK639.0M) exceed its long term liabilities (SEK105.4M).
Debt to Equity History and Analysis
Debt Level: XBRANE's net debt to equity ratio (36%) is considered satisfactory.
Reducing Debt: XBRANE's debt to equity ratio has increased from 0.02% to 47.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XBRANE has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XBRANE has less than a year of cash runway if free cash flow continues to reduce at historical rates of 31.5% each year